Citation Impact
Citing Papers
Metastatic Heterogeneity of Breast Cancer Cells Is Associated with Expression of a Heterogeneous TGFβ-Activating miR424–503 Gene Cluster
2014
miRNA-34 Prevents Cancer Initiation and Progression in a Therapeutically Resistant K-ras and p53-Induced Mouse Model of Lung Adenocarcinoma
2012
MicroRNA Replacement Therapy for miR-145 and miR-33a Is Efficacious in a Model of Colon Carcinoma
2011
An enzymatic toolkit for selective proteolysis, detection, and visualization of mucin-domain glycoproteins
2020 StandoutNobel
Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment
2018 StandoutNobel
Critical contribution of 3′ non-seed base pairing to the in vivo function of the evolutionarily conserved let-7a microRNA
2022 StandoutNobel
Pharmacologic Targeting of Hypoxia-Inducible Factors
2019 StandoutNobel
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
Regulation of the breast cancer stem cell phenotype by hypoxia-inducible factors
2015 StandoutNobel
FoxOs Enforce a Progression Checkpoint to Constrain mTORC1-Activated Renal Tumorigenesis
2010 StandoutNobel
IGF2BP2 regulates DANCR by serving as an N6-methyladenosine reader
2019
Genetic variation at the 8q24.21 renal cancer susceptibility locus affects HIF binding to a MYC enhancer
2016 StandoutNobel
Human RNA Methyltransferase BCDIN3D Regulates MicroRNA Processing
2012
MYC on the Path to Cancer
2012 Standout
Cytokines in CAR T Cell–Associated Neurotoxicity
2020
Ferroptosis as a p53-mediated activity during tumour suppression
2015 StandoutNature
Hydrophobic mismatch drives self-organization of designer proteins into synthetic membranes
2024 StandoutNobel
A Long Noncoding RNA Regulates Sister Chromatid Cohesion
2016
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Regulation of microRNA biogenesis
2014 Standout
Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells
2022 StandoutNobel
The emerging role of lncRNAs in cancer
2015 Standout
Genetic engineering of T cells for immunotherapy
2021
The expanding universe of p53 targets
2009
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
FOXO3, estrogen receptor alpha, and androgen receptor impact tumor growth rate and infiltration of dendritic cell subsets differentially between male and female mice
2017
Role of MicroRNAs in the Regulation of Redox-Dependent Processes
2019
Hypoxia-Inducible Factors: Master Regulators of Cancer Progression
2016 StandoutNobel
Hepatocellular carcinoma
2021 Standout
Genetically engineered T cells for cancer immunotherapy
2019
MUC1 and metastatic cancer
2013
Antiviral resistance of stem cells
2018 StandoutNobel
To repress or not to repress: This is the guardian's question
2011
Glutaminase 1 expression in colorectal cancer cells is induced by hypoxia and required for tumor growth, invasion, and metastatic colonization
2019 StandoutNobel
Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer
2012
New plays in the p53 theater
2010
The complexity of NF-κB signaling in inflammation and cancer
2013 Standout
Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets
2017 StandoutNobel
Metazoan MicroRNAs
2018 Standout
Blinded by the Light: The Growing Complexity of p53
2009 Standout
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
LncRNA loc285194 is a p53-regulated tumor suppressor
2013
An updated review of mechanotransduction in skin disorders: transcriptional regulators, ion channels, and microRNAs
2015
The role of the 3' untranslated region in post-transcriptional regulation of protein expression in mammalian cells.
2012
Intrinsically disordered proteins in cellular signalling and regulation
2014 Standout
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
Programmed Cell Senescence during Mammalian Embryonic Development
2013 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Delivery technologies for T cell gene editing: Applications in cancer immunotherapy
2021
CAR-T cell therapy: current limitations and potential strategies
2021 Standout
m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer
2020 Standout
One Function—Multiple Mechanisms: The Manifold Activities of p53 as a Transcriptional Repressor
2011
MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches
2012
Engineering strategies to overcome the current roadblocks in CAR T cell therapy
2019
The PI3K Pathway in Human Disease
2017 Standout
Endogenous microRNA sponges: evidence and controversy
2016 Standout
Emerging roles of microRNAs in the control of embryonic stem cells and the generation of induced pluripotent stem cells
2010
Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study
2015 Standout
Targeting non-coding RNAs with the CRISPR/Cas9 system in human cell lines
2014
Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer
2014
Gene regulation by long non-coding RNAs and its biological functions
2020 Standout
The first 30 years of p53: growing ever more complex
2009 Standout
MicroRNA
2017 Standout
Modeling neurodevelopmental disorder-associated humanAGO1mutations inCaenorhabditis elegansArgonautealg-1
2024 StandoutNobel
Genome Regulation by Long Noncoding RNAs
2012 Standout
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
2023 StandoutNobel
Tumor cell intravasation
2016
pVHL suppresses kinase activity of Akt in a proline-hydroxylation–dependent manner
2016 StandoutScienceNobel
Wound Healing: A Cellular Perspective
2018 Standout
Cdk2 and Cdk4 Activities Are Dispensable for Tumorigenesis Caused by the Loss of p53
2009
Dauer larva quiescence alters the circuitry of microRNA pathways regulating cell fate progression inC. elegans
2012 StandoutNobel
BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation
2018 StandoutNobel
A bulky glycocalyx fosters metastasis formation by promoting G1 cell cycle progression
2017 StandoutNobel
Regulatory roles of IL-10–producing human follicular T cells
2019 StandoutNobel
Promotion of direct reprogramming by transformation-deficient Myc
2010 StandoutNobel
The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network
2010
Robust Distal Tip Cell Pathfinding in the Face of Temperature Stress Is Ensured by Two Conserved microRNAS inCaenorhabditis elegans
2015 StandoutNobel
Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides
2020 StandoutNobel
Works of Mohit Sachdeva being referenced
p53 represses c-Myc through induction of the tumor suppressor miR-145
2009
MicroRNA-145 Suppresses Cell Invasion and Metastasis by Directly Targeting Mucin 1
2009
Stroma-mediated expression of estrogen and its role in cancer
2009
Granulocyte–macrophage colony-stimulating factor inactivation in CAR T-cells prevents monocyte-dependent release of key cytokine release syndrome mediators
2019
Repurposing endogenous immune pathways to tailor and control chimeric antigen receptor T cell functionality
2019
Negative regulation of miR-145 by C/EBP-β through the Akt pathway in cancer cells
2012
MicroRNA-182 drives metastasis of primary sarcomas by targeting multiple genes
2014
MicroRNA-101-mediated Akt activation and estrogen-independent growth
2010
miR-145-mediated suppression of cell growth, invasion and metastasis.
2010
HIF-1 Alpha Regulates the Response of Primary Sarcomas to Radiation Therapy through a Cell Autonomous Mechanism
2015